Preparation and Evaluation of Animal Models of Cardiotoxicity in Antineoplastic Therapy.
Journal
Oxidative medicine and cellular longevity
ISSN: 1942-0994
Titre abrégé: Oxid Med Cell Longev
Pays: United States
ID NLM: 101479826
Informations de publication
Date de publication:
2022
2022
Historique:
received:
15
04
2022
accepted:
03
06
2022
entrez:
18
7
2022
pubmed:
19
7
2022
medline:
20
7
2022
Statut:
epublish
Résumé
The continuous development of antineoplastic therapy has significantly reduced the mortality of patients with malignant tumors, but its induced cardiotoxicity has become the primary cause of long-term death in patients with malignant tumors. However, the pathogenesis of cardiotoxicity of antineoplastic therapy is currently unknown, and practical means of prevention and treatment are lacking in clinical practice. Therefore, how to effectively prevent and treat cardiotoxicity while treating tumors is a major challenge. Animal models are important tools for studying cardiotoxicity in antitumor therapy and are of great importance in elucidating pathophysiological mechanisms and developing and evaluating modality drugs. In this paper, we summarize the existing animal models in antitumor therapeutic cardiotoxicity studies and evaluate the models by observing the macroscopic signs, echocardiography, and pathological morphology of the animals, aiming to provide a reference for subsequent experimental development and clinical application.
Identifiants
pubmed: 35847594
doi: 10.1155/2022/3820591
pmc: PMC9277159
doi:
Substances chimiques
Antibiotics, Antineoplastic
0
Antineoplastic Agents
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
3820591Informations de copyright
Copyright © 2022 Chenchen Meng et al.
Déclaration de conflit d'intérêts
There is no conflict of interest among the authors.
Références
Radiother Oncol. 2011 Dec;101(3):438-42
pubmed: 21908064
J Clin Oncol. 2007 Aug 10;25(23):3525-33
pubmed: 17687157
Cardiovasc Res. 2020 May 1;116(6):1161-1174
pubmed: 31566215
Cancer Chemother Pharmacol. 2016 Apr;77(4):777-85
pubmed: 26914236
Heart Dis. 2001 May-Jun;3(3):157-68
pubmed: 11975787
Science. 2001 Jan 12;291(5502):319-22
pubmed: 11209085
J Am Soc Echocardiogr. 2009 Apr;22(4):418-24
pubmed: 19269133
Am J Cancer Res. 2020 Feb 01;10(2):536-544
pubmed: 32195025
Am J Vet Res. 2006 Aug;67(8):1319-25
pubmed: 16881842
Oxid Med Cell Longev. 2020 Oct 15;2020:9535426
pubmed: 33178389
Exp Cell Res. 2009 Feb 15;315(4):627-37
pubmed: 18801360
Toxicology. 2022 Jan 15;465:153042
pubmed: 34800596
Int J Impot Res. 2010 Mar-Apr;22(2):77-90
pubmed: 20032988
Eur J Pharmacol. 2018 Jan 5;818:241-253
pubmed: 29074412
Can J Cardiol. 2016 Jul;32(7):831-41
pubmed: 27343741
Circulation. 2004 Nov 2;110(18):2869-74
pubmed: 15505089
Nat Rev Cardiol. 2015 Sep;12(9):547-58
pubmed: 25962976
J Am Coll Cardiol. 2014 Jan 28;63(3):240-8
pubmed: 24161324
ESC Heart Fail. 2021 Apr;8(2):928-937
pubmed: 33529501
Adv Drug Deliv Rev. 2011 Mar 18;63(3):152-60
pubmed: 20840859
Free Radic Res. 2017 May;51(5):449-459
pubmed: 28554248
Sci Rep. 2020 Sep 7;10(1):14693
pubmed: 32895407
Cancer. 2014 May 1;120(9):1290-314
pubmed: 24343171
Eur J Heart Fail. 2002 Jun;4(3):235-42
pubmed: 12034146
Cardiovasc Pathol. 2020 Jan - Feb;44:107159
pubmed: 31743871
Cardiovasc Res. 2020 Feb 1;116(2):383-392
pubmed: 31098627
Nat Med. 2012 Nov;18(11):1639-42
pubmed: 23104132
J Am Soc Echocardiogr. 2011 Jun;24(6):699-705
pubmed: 21353471
Life Sci. 2020 Feb 1;242:117186
pubmed: 31862454
Medicine (Baltimore). 2016 Aug;95(32):e4230
pubmed: 27512838
Int J Toxicol. 2011 Dec;30(6):681-9
pubmed: 21994238
Circulation. 2016 Apr 26;133(17):1668-87
pubmed: 26984939
Antioxidants (Basel). 2019 Sep 01;8(9):
pubmed: 31480577
Clin Cancer Res. 2019 Aug 1;25(15):4735-4748
pubmed: 31085720
Invest New Drugs. 1998;16(2):121-8
pubmed: 9848575
Hum Vaccin Immunother. 2016 May 3;12(5):1124-31
pubmed: 26836985
Am J Physiol Heart Circ Physiol. 2015 Nov;309(9):H1453-67
pubmed: 26386112
Zhongguo Fei Ai Za Zhi. 2021 Jun 20;24(6):394-403
pubmed: 34157799
Eur Heart J. 2016 Sep 21;37(36):2768-2801
pubmed: 27567406
Cancer Discov. 2021 Mar;11(3):614-625
pubmed: 33257470
Bull Cancer. 2016 May;103(5):507-10
pubmed: 26992855
J Natl Cancer Inst. 2012 Sep 5;104(17):1293-305
pubmed: 22949432
Drug Res (Stuttg). 2020 Apr;70(4):165-169
pubmed: 32074649
Physiol Rev. 2014 Jul;94(3):909-50
pubmed: 24987008
Med Oncol. 2016 Aug;33(8):84
pubmed: 27372782
CA Cancer J Clin. 2021 Jan;71(1):7-33
pubmed: 33433946
Scanning Microsc. 1995 Jun;9(2):561-76
pubmed: 8714749
Target Oncol. 2011 Dec;6(4):189-95
pubmed: 22125051
Oncologist. 2008 Jun;13(6):620-30
pubmed: 18586917
J Cardiovasc Pharmacol. 1984 Jan-Feb;6(1):186-200
pubmed: 6199603
J Exp Clin Cancer Res. 2022 Jan 3;41(1):1
pubmed: 34980222
Oxid Med Cell Longev. 2022 Jan 28;2022:6194532
pubmed: 35126817
J Clin Oncol. 2016 Feb 20;34(6):581-7
pubmed: 26392097
Hum Exp Toxicol. 2006 Jun;25(6):305-9
pubmed: 16866187
Biomed Pharmacother. 2021 May;137:111375
pubmed: 33761601
Arch Dis Child. 1994 Nov;71(5):457-62
pubmed: 7826122
Cochrane Database Syst Rev. 2011 Jun 15;(6):CD003917
pubmed: 21678342
J BUON. 2005 Apr-Jun;10(2):205-11
pubmed: 17343330
Cancer Res. 2005 Apr 15;65(8):3100-7
pubmed: 15833839
J Mol Cell Cardiol. 2006 Aug;41(2):228-35
pubmed: 16769082
J Am Soc Echocardiogr. 2020 Oct;33(10):1253-1263
pubmed: 32778498
Bioorg Med Chem Lett. 2019 Jul 15;29(14):1705-1709
pubmed: 31129053
Xenobiotica. 2015 Jan;45(1):79-87
pubmed: 25034007
Biomed Pharmacother. 2017 Sep;93:17-26
pubmed: 28622591
Pharmacogenet Genomics. 2011 Jul;21(7):440-6
pubmed: 21048526
Neth Heart J. 2009 Aug;17(7-8):277-80
pubmed: 19789694
Int J Mol Med. 2013 Feb;31(2):423-9
pubmed: 23254567
Int J Biol Macromol. 2020 Sep 15;159:1084-1093
pubmed: 32442568
Eur J Heart Fail. 2000 Dec;2(4):373-8
pubmed: 11113713
J Pers Med. 2020 Oct 19;10(4):
pubmed: 33086484
Can J Cardiol. 2016 Dec;32(12):1513-1519
pubmed: 27650929
Circulation. 2000 Mar 7;101(9):948-54
pubmed: 10704159
Radiat Res. 2014 Mar;181(3):324-34
pubmed: 24568130
J Control Release. 2010 Mar 19;142(3):299-311
pubmed: 19874861
Aging (Albany NY). 2021 Jan 2;13(3):3699-3711
pubmed: 33406500
Am J Med Sci. 2000 Jul;320(1):59-63
pubmed: 10910374
Ann Oncol. 2011 May;22(5):1120-1126
pubmed: 21097554
J Am Soc Echocardiogr. 2014 May;27(5):568-79
pubmed: 24534652
Eur J Heart Fail. 2019 Apr;21(4):519-528
pubmed: 30843309
Biomed Pharmacother. 2019 May;113:108731
pubmed: 30851549
Front Physiol. 2021 Apr 07;12:658790
pubmed: 33897465
Antioxid Redox Signal. 2013 Mar 10;18(8):899-929
pubmed: 22794198
Ann Pharmacother. 1994 Mar;28(3):374-8
pubmed: 8193429
J Pineal Res. 2011 Jan;50(1):89-96
pubmed: 21062350
Curr Med Chem Anticancer Agents. 2001 Aug;1(2):113-30
pubmed: 12678762
Niger J Physiol Sci. 2021 Jun 30;36(1):57-65
pubmed: 34987247
Cancer Chemother Pharmacol. 2003 Nov;52(5):431-4
pubmed: 14618274
Proc Natl Acad Sci U S A. 2019 Feb 12;116(7):2672-2680
pubmed: 30692261
Circulation. 2006 May 9;113(18):2211-20
pubmed: 16651473
Can J Cardiol. 2014 Mar;30(3):359-67
pubmed: 24484915
Adv Drug Deliv Rev. 2013 Jan;65(1):71-9
pubmed: 23088862
Int Immunol. 2010 Jun;22(6):443-52
pubmed: 20410257
Environ Sci Pollut Res Int. 2021 Jan;28(4):4558-4572
pubmed: 32946057
Int J Radiat Oncol Biol Phys. 2008 Sep 1;72(1):170-7
pubmed: 18632215
J Am Assoc Lab Anim Sci. 2007 Jul;46(4):20-32
pubmed: 17645292
Sci Rep. 2022 May 23;12(1):8661
pubmed: 35606482
J Heart Lung Transplant. 2008 Jan;27(1):86-92
pubmed: 18187092
Crit Rev Oncol Hematol. 2010 Dec;76(3):186-95
pubmed: 20138541
Ann Oncol. 2017 Jul 1;28(suppl_4):iv119-iv142
pubmed: 28881921
N Engl J Med. 2013 Mar 14;368(11):987-98
pubmed: 23484825
Int J Radiat Biol. 2013 Sep;89(9):685-91
pubmed: 23527854